Literature DB >> 32150337

A novel frameshift mutation in SOX10 causes Waardenburg syndrome with peripheral demyelinating neuropathy, visual impairment and the absence of Hirschsprung disease.

Elizabeth A Burke1, Kyle E Reichard1, Lynne A Wolfe1,2, Brian P Brooks3, John J DiGiovanna4, Donald W Hadley2,5, Tanya J Lehky6, Andrea L Gropman5,7, Cynthia J Tifft1,2, William A Gahl1,2,8, Camilo Toro1,2, David Adams1,2.   

Abstract

Waardenburg syndrome (WS) is a group of genetic disorders associated with varying components of sensorineural hearing loss and abnormal pigmentation of the hair, skin, and eyes. There exist four different WS subtypes, each defined by the absence or presence of additional features. One of the genes associated with WS is SOX10, a key transcription factor for the development of neural crest-derived lineages. Here we report a 12-year-old boy with a novel de novo SOX10 frameshift mutation and unique combination of clinical features including primary peripheral demyelinating neuropathy, hearing loss and visual impairment but absence of Hirschsprung disease and the typical pigmentary changes of hair or skin. This expands the spectrum of currently recognized phenotypes associated with WS and illustrates the phenotypic heterogeneity of SOX10-associated WS.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cochlear implant; SOX10; Waardenburg syndrome

Mesh:

Substances:

Year:  2020        PMID: 32150337      PMCID: PMC7167353          DOI: 10.1002/ajmg.a.61542

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.578


  14 in total

1.  The NIH Undiagnosed Diseases Program: lessons learned.

Authors:  William A Gahl; Cynthia J Tifft
Journal:  JAMA       Date:  2011-05-11       Impact factor: 56.272

2.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Analysis of the human SOX10 mutation Q377X in mice and its implications for genotype-phenotype correlation in SOX10-related human disease.

Authors:  Kathrin Truch; Juliane Arter; Tanja Turnescu; Matthias Weider; Anna C Hartwig; Ernst R Tamm; Elisabeth Sock; Michael Wegner
Journal:  Hum Mol Genet       Date:  2018-03-15       Impact factor: 6.150

4.  Electrophysiologic correlates of peripheral nervous system maturation in infancy and childhood.

Authors:  E Parano; A Uncini; D C De Vivo; R E Lovelace
Journal:  J Child Neurol       Date:  1993-10       Impact factor: 1.987

5.  The Sox10(Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome.

Authors:  E M Southard-Smith; M Angrist; J S Ellison; R Agarwala; A D Baxevanis; A Chakravarti; W J Pavan
Journal:  Genome Res       Date:  1999-03       Impact factor: 9.043

6.  A de novo SOX10 mutation causing severe type 4 Waardenburg syndrome without Hirschsprung disease.

Authors:  Yves Sznajer; Cristina Coldéa; Françoise Meire; Isabelle Delpierre; Tayeb Sekhara; Renaud L Touraine
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

7.  The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine.

Authors:  William A Gahl; John J Mulvihill; Camilo Toro; Thomas C Markello; Anastasia L Wise; Rachel B Ramoni; David R Adams; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2016-01-22       Impact factor: 4.797

8.  The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases.

Authors:  William A Gahl; Thomas C Markello; Camilo Toro; Karin Fuentes Fajardo; Murat Sincan; Fred Gill; Hannah Carlson-Donohoe; Andrea Gropman; Tyler Mark Pierson; Gretchen Golas; Lynne Wolfe; Catherine Groden; Rena Godfrey; Michele Nehrebecky; Colleen Wahl; Dennis M D Landis; Sandra Yang; Anne Madeo; James C Mullikin; Cornelius F Boerkoel; Cynthia J Tifft; David Adams
Journal:  Genet Med       Date:  2011-09-26       Impact factor: 8.822

9.  HSP and deafness: Neurocristopathy caused by a novel mosaic SOX10 mutation.

Authors:  Sandra Donkervoort; Diana Bharucha-Goebel; Pomi Yun; Ying Hu; Payam Mohassel; Ahmet Hoke; Wadih M Zein; Daniel Ezzo; Andrea M Atherton; Ann C Modrcin; Majed Dasouki; A Reghan Foley; Carsten G Bönnemann
Journal:  Neurol Genet       Date:  2017-05-15

10.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

View more
  1 in total

1.  A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.

Authors:  Nozomu Matsuda; Koushi Ootsuki; Shunsuke Kobayashi; Ayaka Nemoto; Hitoshi Kubo; Shin-Ichi Usami; Kazuaki Kanani
Journal:  BMC Neurol       Date:  2021-06-25       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.